AC Immune SA (ACIU)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 10:14AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 263.59M |
| Enterprise value | 108.21M |
| Trailing P/E | 11.63 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.27 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -1.49 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.71 |
| 52-week change 3 | -52.70% |
| S&P500 52-week change 3 | -15.36% |
| 52-week high 3 | 8.1400 |
| 52-week low 3 | 2.0600 |
| 50-day moving average 3 | 3.0941 |
| 200-day moving average 3 | 3.7078 |
Share statistics
| Avg vol (3-month) 3 | 58.24k |
| Avg vol (10-day) 3 | 124.3k |
| Shares outstanding 5 | 83.41M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 32.74M |
| % held by insiders 1 | 47.74% |
| % held by institutions 1 | 18.21% |
| Shares short (14 Sept 2022) 4 | 460.3k |
| Short ratio (14 Sept 2022) 4 | 10.23 |
| Short % of float (14 Sept 2022) 4 | 1.17% |
| Short % of shares outstanding (14 Sept 2022) 4 | 0.55% |
| Shares short (prior month 14 Aug 2022) 4 | 461.31k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in CHF.Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Jun 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -23.88% |
| Return on equity (ttm) | -38.60% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | -62.28M |
| EBITDA | -79.88M |
| Net income avi to common (ttm) | -75.68M |
| Diluted EPS (ttm) | -0.9990 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 154.15M |
| Total cash per share (mrq) | 1.83 |
| Total debt (mrq) | 2.63M |
| Total debt/equity (mrq) | 1.29 |
| Current ratio (mrq) | 13.28 |
| Book value per share (mrq) | 2.40 |
Cash flow statement
| Operating cash flow (ttm) | -74.95M |
| Levered free cash flow (ttm) | -47.52M |
© 2022 Yahoo. All rights reserved.
